Ontrak, Inc. (OTRKQ) is a defunct healthcare technology company that previously provided AI-driven behavioral health management services targeting high-cost members with comorbid medical and behavioral conditions. The company filed for bankruptcy and ceased operations, with the 'Q' suffix indicating it trades on OTC markets post-delisting. The stock is essentially worthless with near-zero market cap and no ongoing business operations.
Historically, Ontrak contracted with health insurers and health systems to identify members with behavioral health conditions (substance abuse, depression, anxiety) that drive excess medical utilization. The company used predictive analytics to target high-cost members, then provided telephonic outreach and care coordination to improve engagement with treatment. Revenue was primarily PMPM-based with performance bonuses tied to demonstrated medical cost savings. The business model collapsed due to customer concentration risk (loss of major payer contracts), operational execution issues, and inability to scale profitably. As of March 2026, the company has no operating business.
Bankruptcy proceedings and liquidation timeline - any distributions to equity holders (likely zero)
Delisting status and OTC trading liquidity (essentially illiquid)
Historical: Major payer contract wins/losses (Anthem contract termination was fatal blow)
Historical: Member enrollment growth and engagement rates
Complete loss of equity value - bankruptcy proceedings typically result in zero recovery for common shareholders after creditors are paid
Historical structural issue: Customer concentration risk in healthcare services where loss of single large payer contract can eliminate 30-50% of revenue overnight
Historical: Regulatory risk around healthcare data privacy (HIPAA), telehealth licensing across states, and value-based care reimbursement model acceptance
Historical: Incumbent behavioral health providers (Magellan Health, Optum Behavioral) with established payer relationships and scale advantages
Historical: Payers building in-house behavioral health management capabilities rather than outsourcing
Historical: Inability to demonstrate ROI to payers with sufficient rigor to justify PMPM fees in competitive bidding
Total equity wipeout - current market cap effectively zero with -203.7% ROE indicating complete capital destruction
Current ratio of 0.72x indicates insufficient liquid assets to cover short-term liabilities even before bankruptcy
Negative operating cash flow and free cash flow indicate the business consumed cash until liquidation
Debt/Equity of 2.08x with no ability to service obligations led directly to Chapter 11 or Chapter 7 filing
low - Healthcare services demand is relatively recession-resistant, though payer budget pressures during downturns can impact contract renewals and pricing. For a defunct company, macro conditions are irrelevant to equity value (already zero).
Historically moderate - As an unprofitable growth company, Ontrak was sensitive to rising rates through higher cost of capital and compressed valuation multiples for unprofitable healthcare tech. The company's inability to access capital markets at reasonable terms accelerated its demise. Currently irrelevant given bankruptcy status.
Critical historical factor - The company's overleveraged balance sheet (Debt/Equity 2.08x) and negative cash flow made it unable to refinance or raise additional capital when operational issues emerged. Tightening credit conditions in 2023-2024 eliminated refinancing options, forcing bankruptcy filing.
distressed/bankruptcy - Only highly speculative traders or bankruptcy claims investors would consider this security. The -100% one-year return and -99.5% six-month return reflect complete capital destruction. No rational long-term investor profile exists for a bankrupt entity with zero ongoing operations. Historically attracted unprofitable growth investors betting on healthcare technology disruption.
extreme - The stock has experienced complete collapse with -100% annual return. OTC trading post-delisting creates massive bid-ask spreads and illiquidity. Historical beta likely exceeded 2.0x as an unprofitable small-cap healthcare tech name. Current volatility is meaningless as the security trades at near-zero with no fundamental value.